"…consider using thrombopoietin receptor agonists as first-line therapy for new or relapsed acute ITP during the COVID-19 pandemic in patients who are negative for ...

The clinical course of ITP in children usually differs from that in adults, yet distincttons by marrow characteristics have not been established. Megakaryocytes (megas) were examined for size, ploidy, ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. What is believed to be the first case of thrombosis with thrombocytopenia after a messenger RNA ...

From the Medical Service, Beth Israel Hospital, and the Department of Medicine, Harvard Medical School. Select the format you want to export the citation of this publication.

Reviewed by Julia M. Cunningham, MD, Assistant Professor, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Patients with immune thrombocytopenia (ITP) ...

Yet another paper published in the New England Journal of Medicine is documenting the apparent mechanism behind the risk of thrombosis after vaccination with ChAdOx1 nCoV-19, the vaccine jointly ...

Age, BMI, eGFR, and baseline thrombocytopenia were statistically significant for acute kidney injury after HDMTX, but the strongest correlation was with BMI. Some patients with hematologic cancer and ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for rilzabrutinib (Wayrilz, Sanofi) to treat immune thrombocytopenia (ITP) in adults who are refractory to other ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Spontaneous heparin-induced thrombocytopenia is a pro-thrombotic syndrome in which anti-heparin antibodies ...